US9827234 — Dose-dumping resistant controlled release dosage form
Method of Use · Assigned to Osmotica Kereskedelmi es Szolgaltato KFT · Expires 2037-02-03 · 11y remaining
What this patent protects
This patent protects a controlled-release dosage form of methylphenidate hydrochloride that resists dose dumping when exposed to alcohol.
USPTO Abstract
The present invention provides a simple and improved dose form that is capable of providing a controlled release of methylphenidate contained in the core thereof. The invention also provides methods of administering the dosage form and of treating conditions that are therapeutically responsive to methylphenidate. The dosage form exhibits improved resistance to alcohol-related dose dumping.
Drugs covered by this patent
FDA Patent Use Codes
When a patent is method-of-use, FDA lists it once per applicable indication ("U-code"). Each U-code carves out a specific therapeutic use that generic filers must either license or design around.
| Code | Description | Drug |
|---|---|---|
U-4032 |
— | methylphenidate-hydrochloride |
U-4032 |
— | methylphenidate-hydrochloride |
U-4032 |
— | methylphenidate-hydrochloride |
U-4032 |
— | methylphenidate-hydrochloride |
U-4032 |
— | methylphenidate-hydrochloride |
U-4032 |
— | methylphenidate-hydrochloride |
U-4032 |
— | methylphenidate-hydrochloride |
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.